Efficiency of a dexamethasone nanosuspension as an intratympanic injection for acute hearing loss
Dexamethasone sodium phosphate (Dex-SP) is the most commonly used drug administered via intratympanic injection for the treatment of acute hearing loss, but its penetration efficiency into the inner ear is very low. To address this problem, we evaluated the possibility of administering dexamethasone...
Saved in:
Main Authors: | So-Young Jung (Author), Subin Kim (Author), Zion Kang (Author), Soonmin Kwon (Author), Juhye Lee (Author), Joo Won Park (Author), Kab Sig Kim (Author), Dong-Kee Kim (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and Efficacy of Intratympanic Alpha-Lipoic Acid Injection in a Mouse Model of Noise-Induced Hearing Loss
by: Jae Sang Han, et al.
Published: (2022) -
Dual Viscosity Mixture Vehicle for Intratympanic Dexamethasone Delivery Can Block Ototoxic Hearing Loss
by: Hui Li, et al.
Published: (2021) -
Biosafety and potency of high-molecular-weight hyaluronic acid with intratympanic dexamethasone delivery for acute hearing loss
by: Yu-Jung Hwang, et al.
Published: (2024) -
SYSTEMIC CORTICOSTEROIDS ASSOCIATED WITH INTRATYMPANIC CORTICOSTEROID TREATMENT FOR IDIOPATHIC SUDDEN HEARING LOSS
by: Bogdan Cavaleriu, et al.
Published: (2013) -
Surgical procedure of intratympanic injection and inner ear pharmacokinetics simulation in domestic pigs
by: Adele Moatti, et al.
Published: (2024)